December 18, 2017

Request for FDA Approval of Catheter for Atrial Fibrillation Ablation May Usher in Sea Change

One of the many studies reported on this week at the American Heart Association Scientific Sessions in New Orleans was about an ablation catheter clinical trial (from Biosense Webster) that may finally usher in the first FDA approval of a device for treating atrial fibrillation. Read why this could be good news for anyone with atrial fibrillation.

Read:  Potential for an Atrial Fibrillation Sea Change From Request for FDA Approval of Catheter for Ablation of Atrial Fibrillation

Trackbacks

  1. […] recently reported that an ablation catheter clinical trial would potentially usher in FDA approval of the first device for tre…. That approval was just granted today when the NAVISTAR® THERMOCOOL® Catheter from Biosense […]

Comment